Cannabis sales are hitting records in both the U.S. and Canada. With Schedule III reform advancing, growth is fueling investment and M&A.

Nature’s Miracle plans a $150 million greenhouse in California City. Here is how its scale compares to Glass House and what it means for the California flower market.

Cannabis sales are breaking records nationwide. New York, Missouri, Massachusetts, and emerging markets are driving demand and reshaping the industry.

Cannabis M&A under Schedule III is accelerating as strategic buyers acquire cannabis brands with durable equity, IP, and consumer trust.

How Mid-Market Acquisitions Point to Broader Consolidation Ahead For much of the past several years, cannabis mergers and acquisitions have felt frozen in place. Capital markets were cautious, valuations faltered, and many buyers sat on the sidelines. But that appears to be changing. A series of recent deals — from strategic infrastructure buys to brand consolidations — suggests that cannabis M&A activity is beginning to heat up. While none of these deals are traditional “blo